Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study

被引:4
作者
Debureaux, Pierre-Edouard [1 ,2 ]
Forgeard, Nathalie [2 ,3 ]
Elessa, Dikelele [2 ]
Harel, Stephanie [2 ]
Frenzel, Laurent [4 ]
Royer, Bruno [2 ]
Talbot, Alexis [2 ]
Choquet, Sylvain [3 ]
Davi, Frederic [5 ]
Nguyen-Khac, Florence [5 ,6 ]
Cuccuini, Wendy [7 ]
Cheminant, Morgane [4 ]
Bravetti, Clotilde [5 ]
Lazarian, Gregory [8 ]
Kaltenbach, Sophie [9 ]
Hermine, Olivier [4 ]
Roos-Weil, Damien [3 ]
Espeli, Marion [1 ]
Balabanian, Karl [1 ]
Arnulf, Bertrand [2 ,10 ]
机构
[1] Univ Paris Cite, Inst Rech St Louis, INSERM, EMiLy,U1160, Paris, France
[2] Hosp St Louis, AP HP, Dept Immuno Hematol, Paris, France
[3] Sorbonne Univ, Hosp Pitie Salpetriere, AP HP, Dept Hematol, Paris, France
[4] Hosp Necker, AP HP, Dept Hematol, Paris, France
[5] Hosp Pitie Salpetriere, AP HP, Lab Hematol, Paris, France
[6] Univ Paris Cite, Sorbonne Univ, Ctr Rech Cordeliers, INSERM,UMRS113,Drug Resistance Hematol Malignancie, Paris, France
[7] Hosp St Louis, AP HP, Lab Cytogenet, Paris, France
[8] Hosp Avicenne, AP HP, Lab Hematol, Paris, France
[9] Hosp Necker, AP HP, Lab Hematol, Paris, France
[10] Univ Paris Cite, Dept Immunol, Paris, France
关键词
WALDENSTROM MACROGLOBULINEMIA; IBRUTINIB;
D O I
10.3324/haematol.2023.283141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:325 / 330
页数:6
相关论文
共 17 条
[1]   Five-Year Follow-Up of Ibrutinib Plus Rituximab Vs Placebo Plus Rituximab for Waldenstrom's Macroglobulinemia: Final Analysis From the Randomized Phase 3 iNNOVATE™ Study [J].
Buske, Christian ;
Tedeschi, Alessandra ;
Trotman, Judith ;
Garcia-Sanz, Ramon ;
MacDonald, David ;
Leblond, Veronique ;
Mahe, Beatrice ;
Herbaux, Charles ;
Matous, Jeffrey V. ;
Tam, Constantine S. ;
Heffner, Leonard T. ;
Varettoni, Marzia ;
Palomba, M. Lia ;
Shustik, Chaim ;
Kastritis, Efstathios ;
Treon, Steven P. ;
Ping, Jerry ;
Hauns, Bernhard ;
Arango-Hisijara, Israel ;
Dimopoulos, Meletios A. .
BLOOD, 2020, 136
[2]   Bruton tyrosine kinase inhibitors in the management of Waldenstrom macroglobulinemia [J].
Castillo, Jorge J. ;
Buske, Christian ;
Trotman, Judith ;
Sarosiek, Shayna ;
Treon, Steven P. .
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (02) :338-347
[3]   Dramatic Efficacy of Ibrutinib in a Schnitzler Syndrome Case with Indolent Lymphoma [J].
Claves, Fabien ;
Siest, Romane ;
Lefebvre, Christine ;
Valmary-Degano, Severine ;
Carras, Sylvain .
JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) :1380-1383
[4]   Inflammatory Waldenstrom's macroglobulinaemia: A French monocentric retrospective study of 67 patients [J].
Elessa, Dikelele ;
Debureaux, Pierre-Edouard ;
Villesuzanne, Camille ;
Davi, Frederic ;
Bravetti, Clotilde ;
Harel, Stephanie ;
Talbot, Alexis ;
Oksenhendler, Eric ;
Malphettes, Marion ;
Thieblemont, Catherine ;
Moatti, Hannah ;
Maarek, Odile ;
Arnulf, Bertrand ;
Royer, Bruno .
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (06) :728-735
[5]   Inflammation in Waldenstrom macroglobulinemia is associated with 6q deletion and need for treatment initiation [J].
Forgeard, Nathalie ;
Baron, Marine ;
Caron, Jonathan ;
Boccon-Gibod, Clementine ;
Krzisch, Daphne ;
Guedes, Nayara ;
Morel, Veronique ;
Jacque, Nathalie ;
Ouzegdouh, Maya ;
Choquet, Sylvain ;
Bravetti, Clotilde ;
Nguyen-Khac, Florence ;
Chapiro, Elise ;
Leblond, Veronique ;
Roos-Weil, Damien .
HAEMATOLOGICA, 2022, 107 (11) :2720-2724
[6]   MYD88 mutated and wild-type Waldenstrom's Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4 [J].
Guerrera, Maria Luisa ;
Tsakmaklis, Nickolas ;
Xu, Lian ;
Yang, Guang ;
Demos, Maria ;
Kofides, Amanda ;
Chan, Gloria G. ;
Manning, Robert J. ;
Liu, Xia ;
Chen, Jiaji G. ;
Munshi, Manit ;
Patterson, Christopher J. ;
Castillo, Jorge J. ;
Dubeau, Toni ;
Gustine, Joshua ;
Carrasco, Ruben D. ;
Arcaini, Luca ;
Varettoni, Marzia ;
Cazzola, Mario ;
Treon, Steven P. ;
Hunter, Zachary R. .
HAEMATOLOGICA, 2018, 103 (09) :E408-E411
[7]   CXCR4S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenstrom macroglobulinemia [J].
Gustine, Joshua N. ;
Xu, Lian ;
Tsakmaklis, Nicholas ;
Demos, Maria G. ;
Kofides, Amanda ;
Chen, Jiaji G. ;
Liu, Xia ;
Munshi, Manit ;
Guerrera, Maria Luisa ;
Chan, Gloria G. ;
Patterson, Christopher J. ;
Keezer, Andrew ;
Meid, Kirsten ;
Dubeau, Toni ;
Yang, Guang ;
Hunter, Zachary R. ;
Treont, Steven P. ;
Castillo, Jorge J. .
BLOOD ADVANCES, 2019, 3 (19) :2800-2803
[8]   Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemia [J].
Hodge, Lucy S. ;
Ziesmer, Steven C. ;
Yang, Zhi-Zhang ;
Secreto, Frank J. ;
Novak, Anne J. ;
Ansell, Stephen M. .
BLOOD, 2014, 123 (07) :1055-1058
[9]   A revised international prognostic score system for Waldenstrom's macroglobulinemia [J].
Kastritis, Efstathios ;
Morel, Pierre ;
Duhamel, Alain ;
Gavriatopoulou, Maria ;
Kyrtsonis, Marie Christine ;
Durot, Eric ;
Symeonidis, Argiris ;
Laribi, Kamel ;
Hatjiharissi, Evdoxia ;
Ysebaert, Loic ;
Vassou, Amalia ;
Giannakoulas, Nikolaos ;
Merlini, Giampaolo ;
Repousis, Panagiotis ;
Varettoni, Marzia ;
Michalis, Euridyki ;
Hivert, Benedicte ;
Michail, Michalis ;
Katodritou, Eirini ;
Terpos, Evangelos ;
Leblond, Veronique ;
Dimopoulos, Meletios A. .
LEUKEMIA, 2019, 33 (11) :2654-2661
[10]   Cytogenetic and molecular abnormalities in Waldenstrom's macroglobulinemia patients: Correlations and prognostic impact [J].
Krzisch, Daphne ;
Guedes, Nayara ;
Boccon-Gibod, Clementine ;
Baron, Marine ;
Bravetti, Clotilde ;
Davi, Frederic ;
Armand, Marine ;
Smagghe, Luce ;
Caron, Jonathan ;
Bernard, Olivier A. ;
Susin, Santos ;
Chapiro, Elise ;
Leblond, Veronique ;
Nguyen-Khac, Florence ;
Roos-Weil, Damien .
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) :1569-1579